Fight against oxidation arteries - Prevention of the cardiovascular diseases : hypertension, high blood pressure, the blood pressure, arteriosclerosis, myocardial infarction, venous and arterial thrombosis, retinal thrombosis, cerebrovascular stroke, arteritis obliterans The oxidation of the arteries, a major risk factor in cardiovascular
Adults : min 1 - max 2 daily.
Children (under 12 years) : Contact us or see the sheet Use advice
Duration : minimum 180 days.
Use : after an accident or cv alert, 2 caps per day long-term; in case of risk profile, 2 caps during minimum 6 months then 1 caps per day long-term ; as a precautionary measure in long-term: 1 caps per day in long-term For further information, please consult our pharmacist.
Caution(s) : if used anti-coagulant, consult your doctor before use For any question, don't hesitate to contact our pharmacist
Note(s) : For specific questions, please contact us
Its role is however essential, since this amino acid is the precursor of the vasodilator mediator at the circulatory level, the nitric oxide, still called NO group, well known by the patients affected by angor and who are treated by the "Trinitrine" which releases NO from its principle active the trinitroglycerine.
The NO also has the property to inhibit the progress of the atheroma plaques, it is thus a factor antiatherogenic.
The NO also inhibits the formation of the clot responsible for the thrombosis. It is thus an inhibitive factor of the aggregation of plaques.
An arginine supply induces the production of the group NO and improves the vascular resistance.
It is thus a sulfur amino acid antioxidant chelator of heavy metals.
The taurine is also an inhibitor of the angiotensin II, polypeptide vasoconstrictor known for its hypertensives properties.
But the taurine is also an amino acid involved in the elimination of the cholesterol by the biliary ways under the form of taurocholate. The taurine accelerates the metabolism of bad fats.
The lipoic acid is also an activator of the cellular breath, which plays an essential role in the energy supply (in the form of ATP) at the muscular level and all the more at the level of the cardiac muscle.
It should be note that the lipoic acid can have an action on insulin resistance and from then on the glycemia.
This thioacide under its anti-oxidizing reduced form by these two groups -SH is also used since several years to treat neuropathy often observed in diabetics.
The lipoïc acid also increases the production of reduced glutathione to the arterial level and the article cited above shows that this cofactor also reduces the rate of triglycerides.
A recent article published in the British Newspaper of Pharmacology 2008,153, 1587-1588 describes the protective action of the acid lipoic on the smoother cells which line our vascular system.
The article describes the modes of action and the beneficial effects of the acid lipoic on the aortic rings of rats by the stimulation of synthesis of biochemical compounds physiologically active protecting us against the oxidation.
Its role is to neutralize the free radicals of oxygen by the formation of water by the glutathione peroxidase, provided that the reduced glutathione(GSH) is present and under an active form. What we have planned in our formulation.
So that this neutralization can be made in good conditions, three physiological elements are indispensable and that is why we added zinc, copper and manganese in our food supplement.
These three physiological metals accelerate the speed of the reaction of neutralization of the free radicals by the SOD.
Let us remind that pollutants such as the mercury and the cadmium, more and more present in our food, take the place of zinc, copper and manganese, so blocking the activity of the SOD.
Besides, the consumption of polyunsaturated fatty acids polyunsaturated of omega-3 type and certainly acids EPA and DHA (eicosapentanoic acid and docosahexaenoic acid) from fish oils decrease the incidence of the cardiovascular diseases.
These fatty acids are anti-thombotic.
The protective effect of omega-3 EPA and DHA is reached at doses between 500 mg and 900 mg a day.
The article " n-3 Fatty acids and cariovascular disease " published by Jan L.Breslow in American Journal of Nutrition 2006, 83, 1477-1482 demonstrate that from 3g/day making associations of EPA and DHA leads to a reduced risk of thrombosis, lower blood pressure and a marked improvement in vascular reactivity.
Besides, American Heart Association recommends taking these two fatty acid omega-3 in food complement to reduce the risks of cardiovascular pathologies.